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Editorial
There have been many successful stories about HIV treat-
ment and prevention during the past three decades of the 
AIDS epidemic. Among the successful stories, HIV chemo-
therapy has been a major medical accomplishment in the past 
two decades and has dramatically reduced the morbidity and 
mortality of those with access to care [1]. Since a controlled 
trial demonstrated the efficacy and safety of combination an-
tiretroviral therapy (cART) to treat HIV infection, virologic 
suppression, immune reconstitution, and long-term survival 
of HIV infected persons have been achievable goals.
Even though HIV infection is currently a controllable dis-
ease for patients on successful cART, people living with HIV/
AIDS (PLWHA) are still suffering from social stigmatization in 
many countries, including South Korea [2-4]. Kittner et al. [3] 
reported 36.1% of German HIV subjects rated to feel guilty in 
relation to their infection, and they concluded HIV infected 
patients in Germany still suffer from an elevated level of anxi-
ety and depression that was related with internal stigmatiza-
tion. Stigma has been characterized as self, or internalized, 
stigma, which can limit self-efficacy and empowerment; per-
ceived stigma, the sense of what others think or how they 
might treat persons thought or known to have HIV; and expe-
rienced stigma, the actual experience of discrimination, exclu-
sion, or other social sanctions based on perceived HIV status. 
As Kittner et al. [3] pointed out, patients from the Asia-Pacific 
region including Korea tend to be more anxious to lose family 
and friends after disclosure than other regions [2]. One study 
assessed the prevalence of stigmatizing attitudes in Korean 
adolescents from 2006 to 2011 [4]. The responders discrimi-
nated significantly against those with HIV/AIDS, reporting at-
titudes such as being disgusted by PLWHA, contact avoidance 
of PLWHA, and blaming those with HIV for their infection. A 
global cross-sectional survey of perceived HIV-related stigma 
among 2,035 PLWHA from North America, Europe, Latin 
America, Africa, and the Asia-Pacific region including South 
Korea has been performed [5]. The survey showed 37% of re-
sponders reported loneliness as a result of their HIV status. 
Depression was reported by 27%. While 96% reported disclos-
ing their HIV status to at least one person, 17% of patients who 
reported being in long-term sexual relationships had not dis-
closed their status to their partner. The authors concluded that 
perceived HIV stigma, isolation, and discrimination were per-
sistent even 30 years into the HIV pandemic. 
Stigmatization is harmful for individuals with HIV/AIDS be-
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cause it results it social isolation and various mental illnesses 
such as depression and anxiety [2, 6]. Depression is the most 
common mental illness among HIV-infected persons, affect-
ing up to 50% of PLWHA. The higher prevalence of depression 
in HIV infected persons (20–40% versus 7% in general popula-
tion) is due to stigma, sexual dysfunction, side effects of cART, 
co-morbidities, and so on. In addition, depression can cause 
non-adherence to cART [7]. Song et al. [6] found that de-
pressed Korean patients were more likely to miss clinical ap-
pointments. Poor adherence to cART is associated with viro-
logical failure, HIV resistance, and decreased survival. 
From the perspective of public health, HIV-related stigma is 
a major barrier for people to access HIV testing, care, and 
treatment services [8]. Late presentation into care and delay 
in cART initiation likely generates more secondary HIV infec-
tions, increases morbidity and mortality, diminishes respons-
es to cART, and causes higher health care expenditures. As a 
result, enhancing early diagnosis, access to care, and treat-
ment are very important tasks for public health. Interventions 
to reduce HIV-related stigma are associated with improve-
ments in access to HIV prevention and care services [9, 10]. 
Multidisciplinary HIV/AIDS experts developed recommen-
dations for addressing stigma in the HIV/AIDS epidemic [8]. 
They offered recommendations to overcome the key challeng-
es of defining, measuring, and reducing HIV/AIDS-related 
stigma and assessing the impact of stigma on HIV prevention 
and treatment program effectiveness. We need to develop a 
comprehensive framework for HIV/AIDS stigma and encour-
age the use of valid and reliable stigma measures by research-
ers and program implementers. Stigma-reduction strategies 
should be developed at the intrapersonal, interpersonal, com-
munity, institutional, and governmental levels. 
Addressing HIV-related stigma will benefit individual and 
public health by improving the mental health and treatment 
adherence of individuals and encouraging early testing, ac-
cess to care, and treatments. Multidisciplinary and multifacet-
ed approaches to reduce HIV/AIDS-related stigma should be 
developed. 
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